Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 15.50 GBp
Change Today +0.125 / 0.81%
Volume 41.0K
ODX On Other Exchanges
As of 11:30 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

omega diagnostics group plc (ODX) Snapshot

15.38 GBp
Previous Close
15.38 GBp
Day High
15.50 GBp
Day Low
15.38 GBp
52 Week High
06/9/15 - 26.63 GBp
52 Week Low
09/28/15 - 12.50 GBp
Market Cap
Average Volume 10 Days
0.0071 GBp
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

omega diagnostics group plc (ODX) Related Businessweek News

No Related Businessweek News Found

omega diagnostics group plc (ODX) Details

Omega Diagnostics Group PLC, together with its subsidiaries, manufactures, develops, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases. The Allergy and Autoimmune segment researches, develops, produces, and markets in vitro allergy and autoimmune tests that are used by doctors to diagnose patients with allergies and autoimmune diseases. This segment’s principal products include Allergozyme, Allergodip, and Genesis Elisa. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies consumer food detective test products. Its principal products include Genarrayt/Foodprint, Food Detective, and CNS laboratory service. The Infectious Diseases segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. Its principal products comprise Immutrep Syphilis, Micropath Bacterial tests, and Dengue Elisa. The company offers its products to hospitals, blood banks, clinics, and laboratories through distributors and sales teams in approximately 100 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.

146 Employees
Last Reported Date: 07/8/15
Founded in 1987

omega diagnostics group plc (ODX) Top Compensated Officers

Founder, Chief Executive Officer, Managing Di...
Total Annual Compensation: 145.0K GBP
Group Finance Director, Company Secretary and...
Total Annual Compensation: 115.0K GBP
Group Sales & Marketing Director and Executiv...
Total Annual Compensation: 110.0K GBP
Compensation as of Fiscal Year 2015.

omega diagnostics group plc (ODX) Key Developments

Omega Diagnostics Group PLC Provides Earnings Guidance for the First Half Ended September 30, 2015

Omega Diagnostics Group PLC provided earnings guidance for the first half ended September 30, 2015. Turnover is expected to be £6.15 million, 11% ahead of last year's first half in constant currency terms and 8% ahead of last year's result of £5.69 million on an actual basis.  An increase in gross profit has covered a rise in management costs in line with growth plans such that profit before tax (before acquisition costs, share based payments, IFRS-related discount unwinds and amortisation of intangible assets) is expected to be similar to that achieved in the previous half-year period to 30 September 2014 of £0.56 million.

Omega Diagnostics Group PLC Appoints Colin King as Chief Operating Officer, Effective August 3, 2015; Announces Audited Final Consolidated Financial Results for the Year Ended March 31, 2015

Omega Diagnostics Group PLC announced the appointment of Colin King as Chief Operating Officer from 3 August 2015. The company announced audited final consolidated financial results for the year ended March 31, 2015. For the year, the company reported revenue from continuing operations of £12,105,319 against £11,593,870 a year ago. Operating profit was £672,970 against £527,325 a year ago. Profit before taxation was £684,258 against £543,041 a year ago. Profit for the year was £739,046 against £692,851 a year ago. Basic and diluted earnings per share on profit for the year were 0.7 pence against 0.7 pence a year ago. Adjusted profit before taxation for the year ended 31 March 2015 was £1,373,102 against £1,095,911 a year ago. Adjusted earnings per share on profit for the year were 1.3 pence against 1.2 pence a year ago. Cash flow from operating activities was £1,247,893 against £1,669,107 a year ago. Purchase of property, plant and equipment was £701,565 against £478,968 a year ago. Purchase of intangible assets was £1,394,146 against £1,880,845 a year ago.

Omega Diagnostics Group PLC, Annual General Meeting, Sep 07, 2015

Omega Diagnostics Group PLC, Annual General Meeting, Sep 07, 2015., at 12:00 GMT Standard Time. Location: Omega House, Hillfoots Business Village.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ODX:LN 15.50 GBp +0.125

ODX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ODX.
View Industry Companies

Industry Analysis


Industry Average

Valuation ODX Industry Range
Price/Earnings 23.2x
Price/Sales 1.4x
Price/Book 0.9x
Price/Cash Flow 23.1x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OMEGA DIAGNOSTICS GROUP PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at